智力障碍患者的便秘患病率和处方药的风险:来自英国死亡率计划的调查结果
Christina Roberts1, Jonathon Ding2, Delia Bishara2,3
1Research Facilitation and Delivery Unit, Applied Health Research hub, University of Central Lancashire, UK.
便秘对于智力残疾人来说是一个严重的问题. 处方药物显著增加二次便秘的风险,导致这一脆弱人群的死亡率.
科学领域:
- 医学研究 医学研究
- 公共卫生 公共卫生
- 知识障碍研究 智力障碍研究
背景情况:
- 便秘是智力障碍者中普遍存在的健康问题.
- 相关死亡突出显示了这个人群中便秘的危急性质.
- 风险因素包括生活方式,并发症和多药.
研究的目的:
- 调查智力残疾已故个体中便秘的患病率.
- 为了确定死亡原因和药物诱导便秘的风险.
- 分析药物概况以检测便秘相关的副作用.
主要方法:
- 对2021年去世的智力残疾人的医疗记录进行了回顾性分析.
- 便秘的发生率被确定.
- 药物根据药物概况评估了它们可能引起便秘的药物.
主要成果:
- 在48%的研究样本中出现了便秘.
- 一半的人被处方至少两种药物与已知的便秘副作用.
- 观察到抗精神病 (30%) 和药 (40%) 的处方率很高.
- 有史以来便秘的5人死于与便秘相关的原因.
结论:
- 处方药物对智力障碍患者的二次便秘有很大的风险.
- 这项研究强调了便秘的严重程度及其在这个人口群体中的潜在致命性.
- 医疗保健提供者应仔细审查药物治疗方案,以减轻便秘的风险.
更多相关视频
03:50Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Intellectual Disability
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
